ENLIVEN THERAPEUTICS INC
ELVN·29337E102·US·Common Stock·Healthcare - Biotechnology-Activist
ELVN (ENLIVEN THERAPEUTICS INC) is held by 91 institutional investors as of Q1 2026. Largest holders: FMR LLC ($267.7M), Polar Capital Holdings Plc ($198.6M), BlackRock, Inc. ($144.4M). Net institutional sentiment: Bullish.
91
Holders
Avg rating(18 Elite)
$1.1B
Total Value
75% (99)
Fund Consensus
70 buying - 23 selling
Who's Trading
InsiderKAKunkel Lori AnneSell $205KJul 6, 2026
InsiderKAKunkel Lori AnneSell $299KJul 6, 2026
ActivistOAORBIMED ADVISORS LLC9.5%Jun 24, 2026
InsiderHBHohl BenjaminSell $59KJun 17, 2026
InsiderHBHohl BenjaminSell $149KJun 17, 2026
InsiderHBHohl BenjaminSell $55KJun 17, 2026
ActivistOAORBIMED ADVISORS LLC10.9%Jun 17, 2026
ActivistVHVenrock Healthcare Capital Partners III, L.P.2.8%May 15, 2026
ActivistFAFairmount Funds Management LLC3.1%May 15, 2026
13F: Insider & Congress:
Showing 1-20 of 99
1 / 5
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer